Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Speciale sessie tijdens CROI 2020 gewijd aan COVID-19
mrt 2020 | Longoncologie, Virale infecties